Press Releases

Lexicon Pharmaceuticals to Host Second Quarter 2018 Financial Results Conference Call and Webcast on July 30, 2018	Jul 23, 2018
Lexicon Pharmaceuticals Announces Positive 52-week Results from Sotagliflozin inTandem1 Study Presented at ADA 2018 and Published in Diabetes Care	Jun 24, 2018
Lexicon Pharmaceuticals Announces Positive 52-week Results from Sotagliflozin inTandem2 Study Presented at ADA 2018 and Published in Diabetes Care	Jun 23, 2018
Lexicon Pharmaceuticals to Present New Clinical Data at 78th American Diabetes Association Scientific Sessions	Jun 18, 2018
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference	Jun 05, 2018
FDA to Review Zynquista™ (sotagliflozin) as Potential Treatment for Type 1 Diabetes	May 22, 2018
Lexicon Pharmaceuticals Announces Publication of New Xermelo® (Telotristat Ethyl) Data in Clinical Therapeutics	May 04, 2018
Lexicon Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides a Business Update	May 03, 2018
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference	May 01, 2018
Lexicon Pharmaceuticals to Host First Quarter 2018 Financial Results Conference Call and Webcast on May 3, 2018	Apr 26, 2018